title: Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution.
abstract: BACKGROUND
  Rodent models are a very helpful tool to investigate immunological mechanisms in allograft rejection. The aim of this study was to compare two different immunodeficient recipients in a humanized mouse model of arterial xenotransplantation in terms of reconstitution of the human immune system and rejection of the arterial graft.
  
  
  METHODS
  Side branches of human mammary artery were transplanted as infrarenal aortic interposition grafts into C.B-17-SCID beige and C57BL/6-Rag2(-/-)gammac(-/-) recipients. 7days after surgery mice were reconstituted with 5x10(7) human peripheral blood mononuclear cells (hu PBMCs) and 30days after reconstitution mice were sacrificed and histologic analysis was performed. Peripheral blood and splenocytes were investigated by FACS and ELISA analysis to ensure engraftment of human CD45(+) cells.
  
  
  RESULTS
  Transplant arteriosclerosis developed in non-PBMC-reconstituted C.B-17-SCID beige mice (intimal proliferation: 36.31+/-4.37%), but significantly less in C57BL/6-Rag2(-/-) gammac(-/-) recipients (intimal proliferation: 12.26+/-5.21%). After reconstitution with 5x10(7) unfractionated human PBMCs both mouse strains showed intima proliferation 30days after reconstitution (C.B-17-SCID beige: 28.49+/-7.95% and C57BL/6-Rag2(-/-) gammac(-/-): 44.58+/-11.08%). Whereas only very few human CD45(+) cells were found in mouse blood and spleen of C.B-17-SCID beige mice, C57BL/6-Rag2(-/-) gammac(-/-) mice revealed a reliable reconstitution. In addition, levels of human IgG and IgM within the peripheral blood were markedly higher in C57BL/6-Rag2(-/-) gammac(-/-) recipients.
  
  
  CONCLUSIONS
  In this study we can show, that the use of C57BL/6-Rag2(-/-) gammac(-/-) mice may be advantageous compared to C.B-17-SCID beige recipients in a humanized mouse model of vessel transplantation.
authors.affiliation: Department of Cardiac Surgery, Friedrich-Alexander University, Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
authors.forename: Silke
authors.initials: S
authors.lastname: Abele-Ohl
authors.forename: Martina
authors.initials: M
authors.lastname: Leis
authors.forename: Shohreh
authors.initials: S
authors.lastname: Mahmoudian
authors.forename: Michael
authors.initials: M
authors.lastname: Weyand
authors.forename: Thomas
authors.initials: T
authors.lastname: Stamminger
authors.forename: Stephan M
authors.initials: SM
authors.lastname: Ensminger
mesh_terms: D000818:Animals; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D004268:DNA-Binding Proteins / Q000235:genetics*; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007107:Immune System / Q000276:immunology*; D017493:Leukocyte Common Antigens / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000276:immunology*; D008323:Mammary Arteries / Q000637:transplantation; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D016513:Mice, SCID; D023421:Models, Animal; D014184:Transplantation, Homologous / Q000276:immunology* / Q000379:methods
chemical_list: D004268:DNA-Binding Proteins; C499308:Rag2 protein, mouse; D017493:Leukocyte Common Antigens